Three scientists -- Emmanuelle Charpentier, Jennifer Doudna and Feng Zhang (張鋒) -- were named the winners of the second Tang Prize in biopharmaceutical science on Sunday "for the development of CRISPR/Cas 9 as a breakthrough genome editing platform that promises to revolutionize biomedical research and disease treatment."
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Sports
Chou Tien-chen advances to U.S. Open quarterfinals
06/27/2025 10:46 AM - Society
Taiwan headline news
06/27/2025 10:45 AM - Business
U.S. dollar down in Taipei trading
06/27/2025 10:18 AM - Business
Taiwan shares open higher
06/27/2025 09:19 AM - Politics
Chinese agents surveilled VP Hsiao during 2024 trip: Czech officials
06/26/2025 10:21 PM